Neuroone Medical Technologies (NMTC) Cash from Operations (2010 - 2026)
Neuroone Medical Technologies (NMTC) posted Cash from Operations of 1328711.0 for Q1 2026, up 57.36% on a QoQ basis from 3115835.0 in Q4 2025, and down 2266.61% year-over-year from 61326.65 in Q1 2025.
Neuroone Medical Technologies (NMTC) Cash from Operations (2010 - 2026) Analysis & Trends
Neuroone Medical Technologies' Cash from Operations history runs 17 years deep, the most recent figure standing at 1328711.0 for Q1 2026.
- Quarterly Cash from Operations fell 2266.61% year-over-year to 1328711.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 7433723.0 (down 52.47% YoY) and the FY2025 annual result came in at 2837272.0, up 74.23% from the prior year.
- Cash from Operations was 1328711.0 for Q1 2026 at Neuroone Medical Technologies, up from 3115835.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 1017817.0 in Q3 2022 and bottomed at 3809391.0 in Q4 2023.
- A 5-year average of 2118878.24 and a median of 2636624.0 in 2022 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2022 — Cash from Operations surged 150.16% — and 2026, when it plunged 2266.61%.
- Neuroone Medical Technologies' Cash from Operations stood at 3492253.0 in 2022, then retreated by 9.08% to 3809391.0 in 2023, then jumped by 105.46% to 208049.0 in 2024, then slumped by 1597.64% to 3115835.0 in 2025, then soared by 57.36% to 1328711.0 in 2026.
- Business Quant data shows NMTC's Cash from Operations at 1328711.0 in Q1 2026, 3115835.0 in Q4 2025, and 1525672.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.32 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 581.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 2.57 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 348.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 43.80 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 525.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 220.10 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 290.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Neuroone Medical Technologies | 7.99 Mn | 5.19 Mn | 990,264.00 | -1.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.33 Mn |
| Mar 31, 2026 | -1.33 Mn |
| Dec 31, 2025 | -3.12 Mn |
| Dec 31, 2025 | -3.12 Mn |
| Sep 30, 2025 | -1.53 Mn |
| Sep 30, 2025 | -1.53 Mn |
| Jun 30, 2025 | -1.46 Mn |
| Jun 30, 2025 | -1.46 Mn |
| Mar 31, 2025 | -56,144.00 |
| Mar 31, 2025 | -56,144.00 |
| Dec 31, 2024 | 208,049.00 |
| Dec 31, 2024 | 208,049.00 |
| Sep 30, 2024 | -2.67 Mn |
| Sep 30, 2024 | -2.67 Mn |
| Jun 30, 2024 | -2.36 Mn |
| Jun 30, 2024 | -2.36 Mn |
| Mar 31, 2024 | -2.18 Mn |
| Mar 31, 2024 | -2.18 Mn |
| Dec 31, 2023 | -3.81 Mn |
| Dec 31, 2023 | -3.81 Mn |